Hypoxic prostate/muscle PO2 ratio predicts for biochemical failure in patients with prostate cancer: Preliminary findings

Urology

Volumn 60, Issue 4, 2002, Pages 634-639

  Movsas, Benjamin ^a   Chapman, J Donald ^a   Hanlon, Alexandra L ^a   Horwitz, Eric M ^a   Greenberg, Richard E ^a   Stobbe, Corinne ^a   Hanks, Gerald E ^a   Pollack, Alan ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HORMONE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CHEMICAL ANALYSIS; CONTROLLED STUDY; FOLLOW UP; HEMOGLOBIN DETERMINATION; HORMONAL THERAPY; HUMAN; HYPOXIA; MAJOR CLINICAL STUDY; MALE; MICROELECTRODE; MULTIVARIATE ANALYSIS; MUSCLE; OXYGEN TENSION; PERINEURIUM; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CARCINOMA; RADIATION DOSE; SCORING SYSTEM; SPINAL ANESTHESIA; TREATMENT OUTCOME;

AGED; BRACHYTHERAPY; CELL HYPOXIA; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLE, SKELETAL; OXYGEN; OXYGEN CONSUMPTION; PARTIAL PRESSURE; PROPORTIONAL HAZARDS MODELS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 0036775108     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01858-7     Document Type: Article

References (23)

1. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol. 26:1993;45-50.
2. Nordsmark M., Overgaard M., Overgaard J. Oxygenation status predicts radiation response in advanced squamous cell carcinoma of head and neck. Radiother Oncol. 41:1996;31-39.
3. Nordsmark M., Hoyer M., Keller J., et al. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 35:1996;701-708.
4. 2 homeostasis. Curr Opin Genet Dev. 8:1998;588-594.
5. Cvetkovic D., Movsas B., Dicker A., et al. Increasing hypoxia correlates with increased expression of the angiogenesis marker, VEGF, in human prostate carcinoma. Urology. 57:2001;821-825.
6. Groshar D., McEwan A., Parliament M., et al. Imaging tumor hypoxia and tumor perfusion. J Nucl Med. 34:1993;885-888.
7. Urtasun R., McEwan A., Parliament M., et al. Measurement of hypoxia in human tumors by SPECT imaging of iodoazomycin arabinoside. Br J Cancer. 74:1996;209-212.
8. Rasey J., Koh W., Evans M., et al. Quantifying regional hypoxia in human tumors with positron emission tomography of 18F fluoromisonidazole a pretherapy study of 37 patients . Int J Radiat Oncol Biol Phys. 36:1996;417-428.
9. Movsas B., Chapman J.D., Horwitz E.M., et al. Hypoxic regions exist in human prostate carcinoma. Urology. 53:1999;11-18.
10. 2 study . Cancer. 89:2000;2018-2024.
11. Iyer R., Haynes P., Schneider R., et al. Marking hypoxia in rat prostate carcinomas with B-D-[125I] azomycin galactopyranoside and [99mTc]HL-91 correlation with microelectrode measurements . J Nucl Med. 42:2001;338-344.
12. Nag S., Bice W., DeWyngaert K., et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys. 46:2000;221-230.
13. Vonesh E., Chinchilli V. Linear and Nonlinear Models for the Analysis of Repeated Measurements. 1997;1-560 Marcel Dekker, New York.
14. Vaupel P. Oxygenation of human tumors. Strahlenther Onkol. 166:1990;377-386.
15. Parker C., Milosevic M., Toi A., et al. A polarographic electrode study of tumor oxygenation in localized prostate cancer. Int J Radiat Oncol Biol Phys. 51:2001;78.
16. Nordsmark M., Bentzen S., Overgaard J. Measurement of human tumour oxygenation status by a polarographic needle electrode an analysis of inter- and intratumour heterogeneity . Acta Oncol. 33:1994;383-389.
17. Wong R., Fyles A., Milosevic M., et al. Heterogeneity of polarographic oxygen tension measurements in cervix cancer an evaluation of within and between tumor variability, probe position, and track depth . Int J Radiat Oncol Biol Phys. 39:1997;405-412.
18. Brizel D., Rosner G., Prosnitz L., et al. Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases. Int J Radiat Oncol Biol Phys. 32:1995;1121-1125.
19. Yeh K.A., Biade S., Lanciano M., et al. Polarographic needle electrode measurements of oxygen in rate prostate carcinomas; accuracy and reproducibility. Int J Radiat Oncol Biol Phys. 33:1995;111-118.
20. 2 tension measurements . Cancer Res. 51:1991;3316-3322.
21. Stewart R.J., Panigrahy D., Flynn E., et al. Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts . J Urol. 165:2001;688-693.
22. Borgstrom P., Bourdon M.A., Hillan K.J., et al. Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo. Prostate. 35:1998;1-10.
23. Chapman J., Engelhardt E., Stobbe C., et al. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. Radiother Oncol. 46:1998;229-237.